1. Home
  2. CASI vs PXS Comparison

CASI vs PXS Comparison

Compare CASI & PXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • PXS
  • Stock Information
  • Founded
  • CASI 1991
  • PXS 2015
  • Country
  • CASI China
  • PXS Greece
  • Employees
  • CASI N/A
  • PXS N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • PXS Marine Transportation
  • Sector
  • CASI Health Care
  • PXS Consumer Discretionary
  • Exchange
  • CASI Nasdaq
  • PXS Nasdaq
  • Market Cap
  • CASI 35.0M
  • PXS 38.2M
  • IPO Year
  • CASI 1996
  • PXS N/A
  • Fundamental
  • Price
  • CASI $2.21
  • PXS $3.29
  • Analyst Decision
  • CASI Strong Buy
  • PXS Strong Buy
  • Analyst Count
  • CASI 1
  • PXS 1
  • Target Price
  • CASI $6.00
  • PXS $10.00
  • AVG Volume (30 Days)
  • CASI 8.1K
  • PXS 14.4K
  • Earning Date
  • CASI 03-27-2025
  • PXS 03-21-2025
  • Dividend Yield
  • CASI N/A
  • PXS N/A
  • EPS Growth
  • CASI N/A
  • PXS 63.38
  • EPS
  • CASI N/A
  • PXS 2.85
  • Revenue
  • CASI $22,055,000.00
  • PXS $52,756,000.00
  • Revenue This Year
  • CASI N/A
  • PXS $5.52
  • Revenue Next Year
  • CASI $134.79
  • PXS N/A
  • P/E Ratio
  • CASI N/A
  • PXS $1.17
  • Revenue Growth
  • CASI N/A
  • PXS 4.27
  • 52 Week Low
  • CASI $2.04
  • PXS $3.28
  • 52 Week High
  • CASI $7.67
  • PXS $5.53
  • Technical
  • Relative Strength Index (RSI)
  • CASI 35.91
  • PXS 26.16
  • Support Level
  • CASI $2.15
  • PXS $3.41
  • Resistance Level
  • CASI $2.49
  • PXS $3.53
  • Average True Range (ATR)
  • CASI 0.15
  • PXS 0.09
  • MACD
  • CASI 0.00
  • PXS -0.02
  • Stochastic Oscillator
  • CASI 35.42
  • PXS 4.65

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About PXS Pyxis Tankers Inc.

Pyxis Tankers Inc is an international maritime transportation company that focuses on the product tanker sector. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Pyxis Epsilon, Pyxis Theta, Pyxis Malou, Northsea Alpha, and Northsea Beta. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals.

Share on Social Networks: